Drug Topics

AUGUST 29, 2023

Filling prescriptions for animals is essentially the same as filling prescriptions for humans—with some key differences.

187

187

Pharmacy Times

AUGUST 30, 2023

The opioid settlement framework could have a significant impact on the future of cannabis distribution and its role in health care.

169

169

STAT

AUGUST 29, 2023

WASHINGTON — Medicare on Tuesday announced it will negotiate prices for 10 drugs, including major blood thinners and diabetes medications, in the first round of its negotiation program created in Democrats’ drug pricing reform law. The drugs include Bristol Myers Squibb’s blood thinner Eliquis, Boehringer Ingelheim and Eli Lilly’s diabetes drug Jardiance, Johnson & Johnson’s blood thinner Xarelto, Merck’s diabetes drug Januvia, AstraZeneca’s d

145

145

Fierce Pharma

AUGUST 30, 2023

After 16 years on the market, Takeda's blockbuster attention-deficit/hyperactivity disorder (ADHD) med Vyvanse has finally reached its patent cliff. | After 16 years on the market, Takeda's blockbuster ADHD med Vyvanse has finally reached its patent cliff. And the FDA's approval of several generics comes amid a U.S. shortage of the drug.

FDA 138

FDA 138

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Topics

AUGUST 28, 2023

A recent systematic review found no serious adverse events related to the use of cannabis for the management of cancer-related symptoms in children.

187

187

Pharmacy Times

AUGUST 31, 2023

The seamless integration of artificial intelligence and machine learning has the potential to accelerate research and enhance efficiency in a new era of personalized medicine.

169

169

Fierce Healthcare

AUGUST 31, 2023

Enforcement of information blocking penalties for health IT entities is slated to go into effect on Friday, opening the door to penalties of up to $1 million per violation. | The Department of Health and Human Services Office of Inspector General said it expects to receive more complaints than it can investigate and so will be prioritizing those meeting certain criteria.

135

135

Drug Topics

AUGUST 28, 2023

A recent study found that there was a lack of strong evidence supporting the use of continuous glucose monitor programs in community pharmacies.

Community Pharmacies 187

Community Pharmacies 187

Pharmacy Times

AUGUST 30, 2023

Sodium chloride injection contains sodium chloride in water and is administered intravenously, which is intended for a single-dose injection to replenish fluids and electrolytes.

FDA 149

FDA 149

STAT

AUGUST 30, 2023

Medicaid warned states Wednesday that they could be mistakenly removing children from government insurance programs in a post-pandemic review of millions of enrollees. States may be unnecessarily disenrolling children from Medicaid or the Children’s Health Insurance Program because they are reviewing families as a whole despite there being a higher threshold to remove children from the programs.

Insurance 143

Insurance 143

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

AUGUST 30, 2023

Humana's senior-focused primary care business, CenterWell, is bringing its services into patients' homes. | Humana's senior-focused primary care business, CenterWell, is bringing its services into patients' homes.

134

134

Drug Topics

AUGUST 30, 2023

Resources with pertinent information are essential in motivating individuals to comply with vaccine recommendations.

Vaccines 186

Vaccines 186

Pharmacy Times

AUGUST 31, 2023

Ferric carboxymaltose was not found to have a significant impact on 6-minute walk distance, which is part of the primary outcome’s hierarchical composite of death and hospitalizations from heart failure.

Hospitals 145

Hospitals 145

STAT

SEPTEMBER 1, 2023

In the midst of the Covid-19 surge during the winter of 2021, the Pittsburgh-based UPMC health system received 450 doses of Evusheld — a scarce antibody cocktail being used at the time to prevent immunocompromised patients from being infected by the coronavirus. But those doses were just a fraction of a percent of what the sprawling 35-hospital system needed to protect its 200,000 immunocompromised patients.

Hospitals 141

Hospitals 141

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

AUGUST 30, 2023

In a letter sent to all states (PDF), the Centers for Medicare & Medicaid Services ( | As more Medicaid beneficiaries are wrongly kicked off the program, CMS is requiring states to reevaluate its eligibility systems and auto-renewal process.

132

132

Drug Topics

AUGUST 31, 2023

Sometimes, breaches in information are the result of a simple mistake. How can those be avoided?

HIPAA 200

HIPAA 200

Pharmacy Times

SEPTEMBER 1, 2023

In a previous trial, DARE-19, investigators reported that the SGLT2 inhibitor dapagliflozin did not benefit patients with COVID-19 who had cardiometabolic risk factors.

Hospitals 139

Hospitals 139

STAT

AUGUST 31, 2023

After an expansive investigation found manipulated data and other issues with papers co-authored by Stanford’s now ex-president Marc Tessier-Lavigne , the prominent neuroscientist on Thursday retracted two studies published in the journal Science in 2001 — over the objection of a former postdoctoral researcher who played a leading role in both projects.

141

141

Fierce Healthcare

AUGUST 30, 2023

GoodRx has launched a new feature to allow healthcare professionals to see the cost of a patient’s prescription with their insurance. | The feature, embedded in GoodRx's provider solution, surfaces a patient’s coverage and benefits at the point of care with the goal of increasing price transparency and access to drugs.

Insurance Coverage 129

Insurance Coverage Insurance 129

Drug Topics

AUGUST 29, 2023

Caring for pets is easier when a pharmacist is involved.

Independent Pharmacies 187

Independent Pharmacies 187

Pharmacy Times

AUGUST 28, 2023

Advanced technology can automate many pharmacovigilance tasks to build workflow efficiencies, reduce manual intervention, and free up team members for more strategic activities.

123

123

STAT

AUGUST 31, 2023

The pharmaceutical industry has been up in arms over Medicare’s first list of 10 prescription drugs that will be subject to negotiations. But other major parts of the health care industry — hospitals, doctors, and other providers — have refrained from either lending support or criticizing the government’s process. The American Hospital Association, the industry’s main lobbying group, told STAT it is “not commenting on this issue right now.

Pharmaceutical Companies 141

Pharmaceutical Companies Pharmaceutical Companies Nursing Homes Hospitals 141

Fierce Healthcare

AUGUST 30, 2023

In order to address deteriorating adolescent mental health, interventional behavioral health app BeMe Health moved to meet teens where they’re at—online. | In order to address deteriorating adolescent mental health, interventional behavioral health app BeMe Health moved to meet teens where they’re at—online. Amd according to new research, this methodology is proving successful.

129

129

Fierce Pharma

SEPTEMBER 1, 2023

After months of legal wrangling, Amgen is free to go forward with its $27.8 billion buyout of Horizon Therapeutics. | Friday, the U.S. Federal Trade Commission (FTC) said it reached a proposed consent order with Amgen to address “the potential competitive harm” that could result from the merger deal. Now, Amgen is free to go forward with its $28 billion buyout.

128

128

Pharmacy Times

AUGUST 29, 2023

Nirsevimab (Beyfortus) is the first respiratory syncytial virus (RSV) preventative drug to be approved by the FDA, and can protect infants through their first RSV season for up to 5 months.

FDA 123

FDA 123

STAT

AUGUST 31, 2023

Because Covid cases and hospitalizations are no longer front-page news, many Americans might be surprised to learn that we are in the midst of a mini-surge. The latest data from the Centers for Disease Control and Prevention, from Aug. 12, confirm a 21.6% increase in Covid-19 hospitalizations from the prior week and a 21.4% increase in Covid-related deaths, demonstrating that Covid is not over and that Latinos and Blacks have reason to be concerned.

Hospitals 135

Hospitals 135

Fierce Healthcare

AUGUST 31, 2023

Digital mental health company Headspace is teaming up with Castell, Intermountain Healthcare’s value-based care subsidiary, to expand access to virtual mental health services. | The partnership will provide members of select insurance plans in Utah access to Headspace’s self-guided content, behavioral health coaching and therapy in an outcomes-based payment model.

Insurance 121

Insurance 121

Fierce Pharma

AUGUST 30, 2023

Last month, during a quarterly conference call—as Johnson & Johnson considered its future beyond the separation of its consumer health unit—Chief Financial Officer Joe Wolk described the compan | Last month, during a quarterly conference call—as Johnson & Johnson considered its future beyond separation of its consumer health unit—Chief Financial Officer Joe Wolk described the company’s appetite for M&A as “voracious.

127

127

Pharmacy Times

AUGUST 29, 2023

The supplemental biologics license application for amivantamab-vmjw (Rybrevant) is supported by data from the phase 3 PAPILLON trial, evaluating the efficacy and safety of the drug in combination with chemotherapy for those with non–small cell lung cancer.

Chemotherapy 123

Chemotherapy 123

STAT

SEPTEMBER 1, 2023

The U.S. is running low on primary care physicians, with an estimated shortage of between 17,800 and 48,000 predicted by 2034. The dearth of doctors in this area has broad ramifications, ranging from more patients seeking care from specialty and emergency medicine to increased costs to the health care system  and poorer public health outcomes. One of the challenges to growing the ranks of primary care doctors is that family physicians and others in primary care typically have a much lower i

134

134

The Thyroid Pharmacist

SEPTEMBER 1, 2023

A few years ago, I visited with family in Poland. At that time, one of my cousins was attending dental school in the European Union. She asked me, “Izabella, is it true that the U.S. government adds fluoride to their water supply, in an effort to reduce dental cavities, instead of educating the public about the effect of sugar consumption and nutrition on health?

Compounding 115

Compounding Adverse Reactions Chemotherapy Labelling 115

Fierce Pharma

AUGUST 30, 2023

Even without an FDA approval, Roche’s cancer drug Avastin is widely used by doctors to treat certain eye diseases. | Even without an FDA approval, Roche’s cancer drug Avastin is widely used by doctors to treat certain eye diseases. Outlook Therapeutics has been trying to get an official approval for a reformulated version, but instead got a rejection letter.

FDA 126

FDA 126

Pharmacy Times

AUGUST 28, 2023

Although the patient demographics are similar for the 3 categories of hemolytic reactions with intravenous immunoglobulin, the reaction with delayed hemolytic transfusion reactions was highest compared to the other 2 hemolytic reactions.

123

123

STAT

AUGUST 31, 2023

At long last, naloxone is available over the counter.  But now comes a moment of truth for the overdose-reversal medication: Will increased access help to save lives? And more immediately, can everyone who wants to buy naloxone at a pharmacy afford it?

Insurance 133

Insurance 133